Iambic Therapeutics, Inc. (IAM) vs Valneva SE Sponsored ADR (VALN)

Iambic Therapeutics, Inc. IAM 10.20 −12.37%
Valneva SE Sponsored ADR VALN 5.57 −1.24%

Iambic Therapeutics, Inc. and Valneva SE Sponsored ADR are both Biotechnology companies. Iambic Therapeutics, Inc. and Valneva SE Sponsored ADR are of similar size ($551.7M and $536.5M).

Metric	IAM	VALN	Biotechnology median
P/E	—	59.26	10.60
P/S	—	3.02	9.40
P/B	—	5.26	2.13
Price to free cash flow	—	n/m	25.18
EV/EBITDA	—	42.64	0.66
EV/Sales	—	3.47	9.02
Earnings yield	—	1.69%	(32.88%)
Free cash flow yield	—	(11.87%)	(23.13%)

Metric	IAM	VALN	Biotechnology median
Gross margin	—	38.28%	68.51%
Operating margin	—	13.56%	0.00%
Net margin	—	(12.01%)	0.00%
Free cash flow margin	—	0.00%	0.00%
Return on equity	—	0.00%	(51.96%)
Return on assets	—	0.00%	(46.06%)
Return on invested capital	—	0.00%	0.00%

Metric	IAM	VALN	Biotechnology median
Revenue growth (TTM)	—	(53.16%)	6.76%
EPS growth (last fiscal year)	—	(805.88%)	29.88%
Revenue growth, 5-year CAGR	—	9.41%	9.75%
Net income growth, 5-year CAGR	—	0.00%	0.00%

Metric	IAM	VALN	Biotechnology median
Debt to equity	—	2.27	0.00
Current ratio	—	2.16	4.97
Net debt to EBITDA	—	(1.15)	1.01

Metric	IAM	VALN	Biotechnology median
Dividend yield	—	—	0.41%
Payout ratio	—	—	—

Metric	IAM	VALN	Biotechnology median
Market cap	551.74m	536.53m	161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack